Increased erbB3 promotes erbB2/neu-driven mammary tumor proliferation and co-targeting of erbB2/erbB3 receptors exhibits potent inhibitory effects on breast cancer cells

The kinase deficient erbB3 receptor frequently co-expresses and interacts with erbB2 in human breast cancer to activate the oncogenic signaling pathways, and thus promote breast cancer cell survival/proliferation. In the current study, we discovered that the expression of endogenous mouse erbB3 was...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Int J Clin Exp Pathol
Main Authors: Lyu, Hui, Huang, Jingcao, Edgerton, Susan M, Thor, Ann D, He, Zhimin, Liu, Bolin
Format: Artigo
Jezik:Inglês
Izdano: e-Century Publishing Corporation 2015
Teme:
Original Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4525826/
https://ncbi.nlm.nih.gov/pubmed/26261492
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki